Loading...

晚期NSCLC患者血清EGFR基因突变状态的测定及意义

BACKGROUND AND OBJECTIVE: Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs) has shown a high response rate in the treatment of lung cancer in patients with (EGFR) mutation. The aim of this study is to evaluate the relationship between EGFR mutation status in serum and predictin...

Full description

Saved in:
Bibliographic Details
Published in:Zhongguo Fei Ai Za Zhi
Format: Artigo
Language:Inglês
Published: 中国肺癌杂志编辑部 2013
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6000571/
https://ncbi.nlm.nih.gov/pubmed/23769345
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3779/j.issn.1009-3419.2013.06.06
Tags: Add Tag
No Tags, Be the first to tag this record!